Information Journal Paper
APA:
Copy. (2018). Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 9(8), 259-268. SID. https://sid.ir/paper/769038/en
Vancouver:
Copy. Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM[Internet]. 2018;9(8):259-268. Available from: https://sid.ir/paper/769038/en
IEEE:
Copy, “Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter,” THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, vol. 9, no. 8, pp. 259–268, 2018, [Online]. Available: https://sid.ir/paper/769038/en